Two VCs from Merck Global Health Innovation Fund recently offered fundraising advice for digital health companies. They told these firms to expect slower funding timelines, urged them not to be afraid of down or flat rounds, and advised them to spend time nailing down the specifics of their growth narrative.
In an interview, Nathan Ray, a partner with the healthcare and life practice who oversees M&A/PE related work in that industry for West Monroe, highlighted how his firm works with companies to drive due diligence for clients, and help acquired companies address issues and differentiate during holds. Learn More>>
Based upon survey feedback from last year's attendees: 1) Find Partners/Networking; 2) is a tie between, Meet Investors/Get Funding and Learn from Panel Discussions and Speakers; 3) is another tie between, Discover Startups and Learn About Innovation Opportunities. Don't miss out on your opportunity to gain all of this and more. Join Us October 26th at Pegasus Park in Dallas, TX.
Six months after Esai Alzheimer's disease drug Leqembi received accelerated FDA approval, the agency has awarded the drug full approval. While the agency's regulatory decision sets precedent for other Alzheimer's drugs, it also flags serious safety risks.
The healthcare industry will continue to shift more toward more home-based care offerings in the coming years, 7WireVentures said in a new report. The venture firm also gave some other predictions — including that established healthcare stakeholders will be forced to partner with non-traditional digital health companies and that the greater use of home-based solutions will lead to more personalized care plans.
A Health Affairs study discovered that nearly two-thirds of Medicare Advantage psychiatrist networks, or 64.6%, were narrow in 2019. Comparatively, about 43.1% of Medicaid managed care networks were narrow and 39.5% of ACA Marketplaces were narrow.
Alfie Health's $2.1 million seed funding was led by Y Combinator and Nina Capital. It included participation from Goodwater Capital, Phoenix Investment Club and several angel investors.
CorEvitas brings Thermo Fisher Scientific registries that gather data about how approved therapies are working in the real world. The acquisition will complement PPD, the contract research organization that Thermo Fisher purchased in 2021.
We're proud to introduce Payer's Place, a series of video interviews spotlighting perspectives from senior payer executives. The series will share insights from payers based on developments and trends they've seen in the healthcare industry and what keeps them up at night.
Kicking off the series are interviews with executives from Humana and SCAN Health Plan, which are available to view on demand in the HLTH Community.
No comments